+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

The impact of highly active antiretroviral therapy on the incidence of CMV disease in AIDS patients



The impact of highly active antiretroviral therapy on the incidence of CMV disease in AIDS patients



Abstracts of the Interscience Conference on Antimicrobial Agents & Chemotherapy 37: 248




Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 033835682

Download citation: RISBibTeXText


Related references

Favorable Impact of Highly Active Antiretroviral Therapy on Response to Therapy and Survival in Patients with AIDS-Related Hodgkins Disease. Blood 100(11): Abstract No 4709, 2002

Impact of highly active antiretroviral therapy on onset of Mycobacterium avium complex infection and cytomegalovirus disease in patients with AIDS. Aids 14(16): 2593-2596, 2000

Impact of highly active antiretroviral therapy on individual AIDS-defining illness incidence and survival in Australia. Journal of Acquired Immune Deficiency Syndromes 29(4): 388-395, 2002

The impact of highly active antiretroviral therapy on the incidence and outcomes of AIDS-defining cancers in Southern Alberta. HIV Medicine 7(6): 369-377, 2006

Impact of highly active antiretroviral therapy on plasma MCP-1 and MSP in AIDS patients. Zhejiang Da Xue Xue Bao. Yi Xue Ban 36(2): 174-178, 2007

The changing incidence of AIDS events in patients receiving highly active antiretroviral therapy. Archives of Internal Medicine 165(4): 416-423, 2005

Changing incidence and survival in patients with aids-related non-Hodgkin's lymphomas in the era of highly active antiretroviral therapy (HAART). Leukemia and Lymphoma 41(1-2): 105-116, 2001

Impact of highly active antiretroviral therapy in the clinical, immunological and virological response from AIDS patients. Revista Cubana de Medicina Tropical 59(2): 139-148, 2013

Impact of long-term highly active antiretroviral therapy on bone metabolism in AIDS patients. Zhejiang Da Xue Xue Bao. Yi Xue Ban 45(3): 228-235, 2016

Incidence of and risk factors for visual acuity loss among patients with AIDS and cytomegalovirus retinitis in the era of highly active antiretroviral therapy. Ophthalmology 113(8): 1432-1440, 2006

Incidence of non-AIDS-defining cancers before and during the highly active antiretroviral therapy era in a cohort of human immunodeficiency virus-infected patients. Journal of Clinical Oncology 21(18): 3447-3453, 2003

AIDS incidence and mortality in a hospital-based cohort of HIV-1-seropositive patients receiving highly active antiretroviral therapy in São Paulo, Brazil. Aids Patient Care and Stds 17(9): 447-452, 2003

Favorable impact of virological response to highly active antiretroviral therapy on survival in patients with AIDS-related lymphoma. Leukemia and Lymphoma 43(9): 1837-1842, 2002

Impact of highly active antiretroviral therapy on the incidence of visceral leishmaniasis in a French HIV-infected cohort patients. Abstracts of the Interscience Conference on Antimicrobial Agents & Chemotherapy 41: 495, 2001

The impact of highly active antiretroviral therapy on non-AIDS-defining cancers among adults with AIDS. American Journal of Epidemiology 165(10): 1143-1153, 2007